BASF’s Uvinul 3030 Received FDA Approval - News Item

May 1 2003

Related Stories

The US Food and Drug Administration (FDA) have just approved BASF’s UV absorber Uvinul® 3030 for use in food contact applications. This follows on from the granting of similar approvals by the European Union (EU).

Uvinul® 3030 is used with polymers such as polycarbonate, polyethylene terephthalate (PET) and polyethersulfone which are processed at high temperatures. These materials may be used in applications such as packaging, storage vessels and kitchenware, where they may come into contact with food.

Uvinul® 3030 has an unusually high thermal stability and low volatility as well as UV absorption properties and is suited to high transparency applications such as atrium panes.

 

Posted April 30th, 2003

 

Tell Us What You Think

Do you have a review, update or anything you would like to add to this article?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback